Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects Publications, Year: 2021, Highlighted ArticlesScienceSitesSeptember 30, 2021S1P and MS Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes